Jeronimo
Martinez Garcia
Asociado Ciencias de la Salud
José Alejandro
Pérez Fidalgo
Publicacións nas que colabora con José Alejandro Pérez Fidalgo (4)
2024
-
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
The Lancet, Vol. 403, Núm. 10421, pp. 31-43
-
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Gynecologic Oncology, Vol. 185, pp. 202-211
2023
-
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
Journal of Clinical Oncology
2021
-
SEOM clinical guideline in ovarian cancer (2020)
Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 961-968